Cubist Systematic Strategies’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$251K Buy
+6,264
New +$236K ﹤0.01% 2582
2024
Q1
Sell
-4,067
Closed -$90.6K 3647
2023
Q4
$90.6K Buy
+4,067
New +$91.1K ﹤0.01% 3194
2022
Q4
Sell
-46,593
Closed -$1.32M 4200
2022
Q3
$1.32M Buy
46,593
+35,806
+332% +$960K 0.01% 2378
2022
Q2
$239K Buy
+10,787
New +$244K ﹤0.01% 3587
2022
Q1
Sell
-67,029
Closed -$2.2M 3530
2021
Q4
$2.2M Buy
67,029
+51,323
+327% +$2.07M 0.02% 1279
2021
Q3
$725K Buy
15,706
+12,493
+389% +$604K 0.01% 1769
2021
Q2
$177K Sell
3,213
-65,903
-95% -$3.69M ﹤0.01% 2605
2021
Q1
$3.57M Sell
69,116
-7,017
-9% -$348K 0.05% 637
2020
Q4
$3.3M Sell
76,133
-70,139
-48% -$2.77M 0.05% 664
2020
Q3
$5.12M Buy
146,272
+142,311
+3,593% +$6.24M 0.08% 402
2020
Q2
$212K Sell
3,961
-8,456
-68% -$392K ﹤0.01% 2002
2020
Q1
$441K Buy
+12,417
New +$574K 0.01% 1320
2019
Q4
Sell
-57,675
Closed -$1.87M 2392
2019
Q3
$1.87M Buy
57,675
+38,039
+194% +$1.57M 0.04% 655
2019
Q2
$979K Buy
+19,636
New +$1.05M 0.02% 1057
2019
Q1
Sell
-19,626
Closed -$905K 2221
2018
Q4
$905K Buy
19,626
+19,258
+5,233% +$1.19M 0.04% 609
2018
Q3
$28K Sell
368
-782
-68% -$62.9K ﹤0.01% 1772
2018
Q2
$97K Buy
1,150
+950
+475% +$82.8K ﹤0.01% 1543
2018
Q1
$16K Buy
200
+100
+100% +$7.73K ﹤0.01% 1755
2017
Q4
$6K Sell
100
-2,291
-96% -$144K ﹤0.01% 1862
2017
Q3
$160K Sell
2,391
-1,032
-30% -$62K 0.01% 1523
2017
Q2
$176K Buy
3,423
+3,123
+1,041% +$160K 0.01% 1333
2017
Q1
$18K Sell
300
-366
-55% -$17.5K ﹤0.01% 1550
2016
Q4
$28K Sell
666
-2,513
-79% -$132K ﹤0.01% 1620
2016
Q3
$168K Sell
3,179
-7,969
-71% -$347K 0.01% 1329
2016
Q2
$467K Buy
11,148
+6,319
+131% +$312K 0.03% 816
2016
Q1
$196K Buy
+4,829
New +$206K 0.01% 1233
2014
Q4
Sell
-3,842
Closed -$236K 1859
2014
Q3
$236K Buy
+3,842
New +$166K 0.01% 1263

Other funds holding AGIO